FDA approves Watson's Nabumetone Tablets for treatment of osteoarthritis, RA
Links shared publicly online about this topic.
- 211total visits
FDA approves Watson's Nabumetone Tablets for treatment of osteoarthritis, RA
Watson Pharmaceuticals, Inc. today announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration (FDA) for Nabumetone Tablets USP, 500 mg and 750 mg.
View full resource at news-medical.net
Tags: Arthritis Medication, Osteoarthritis, Pharma, FDA, NSAIDs, Relafen, Watson Pharmaceuticals
Most Recently Shared on June 18, 2011 at 4:43 am By:
FDA approves Watson's Nabumetone Tablets for treatment of osteoarthritis, RA: Watson Pharmaceuticals, Inc. today... http://bit.ly/mqmBqZ
Also Shared By:
Advertisement
Osteoporosis_OW
@Osteoporosis_OW
FDA approves Watson's Nabumetone Tablets for treatment of osteoarthritis, RA: Watson Pharmaceuticals, Inc. today... http://bit.ly/mqmBqZ
1 year ago...